Supply of Beyfortus, the vaccine used to protect infants against respiratory syncytial virus (RSV), is in limited supply due to high demand, according to the Centers for Disease Control.

Beyfortus is used for infants labeled as high-risk and those under six months of age with underlying health conditions.